A leading critic says that the FDA has been remiss for not removing a stent from the market although strong evidence exists that its use leads to more deaths and strokes. … Now, in a paper published in BMJ, a group of physicians led by Rita Redberg say that by not removing Wingspan from the market the…

Click here to continue reading…